Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(33%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
6
67%
Ph phase_2
3
33%

Phase Distribution

6

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
6(66.7%)
Phase 2Efficacy & side effects
3(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (66.7%)
Phase 23 (33.3%)

Trials by Status

completed556%
active_not_recruiting111%
recruiting222%
terminated111%

Recent Activity

3 active trials
Showing 5 of 9
recruitingphase_2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

NCT06143956
completedphase_1

A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

NCT06869018
active_not_recruitingphase_2

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06683508
recruitingphase_1

A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity

NCT07232732
completedphase_1

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

NCT07073170
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06143956Phase 2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Recruiting
NCT06869018Phase 1

A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

Completed
NCT06683508Phase 2

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

Active Not Recruiting
NCT07232732Phase 1

A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity

Recruiting
NCT07073170Phase 1

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

Completed
NCT07085468Phase 2

A Study of LY3549492 in Healthy Weight Adult Participants

Terminated
NCT05327595Phase 1

A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

Completed
NCT06194500Phase 1

A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants

Completed
NCT04758234Phase 1

A Study of LY3549492 in Healthy Participants

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9